When discussing fertility preservation options among transgender patients, it is critical to keep barriers to access in mind.

Children on the path to obesity can be detected as early as age 3.5 years, according to a study published online.

Treatments for multiple myeloma, melanoma, NSCLC, phenylketonuria, C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis are under review.